Pronóstico del mercado de adyuvantes para vacunas en Oriente Medio y África hasta 2030: análisis regional por clase de adyuvante (adyuvante de sal mineral, adyuvante de emulsión, adyuvante de liposoma y otros) y tipo (adyuvante para vacunas humanas y adyuvante para vacunas veterinarias)
Los avances tecnológicos impulsan el mercado de adyuvantes para vacunas en Oriente Medio y África
Actualmente, los adyuvantes a base de sal de aluminio o gel se utilizan predominantemente en vacunas autorizadas. El adyuvante de monofosforil lípido A (MPL) y los copolímeros hidrófobos son ejemplos de estos componentes. Las microesferas hidrófobas plantean desafíos durante la producción de vacunas. Los problemas incluyen muchos problemas de eliminación y contaminación de desechos ambientales y requieren mucho tiempo, son costosos e ineficientes. Por lo tanto, los fabricantes están haciendo hincapié en el desarrollo de nuevas tecnologías para evitar el uso de disolventes orgánicos. Por ejemplo, la tecnología de adyuvantes para vacunas de Aphios abarca la nanotecnología, y su producción incluye fluidos supercríticos, críticos o casi críticos con o sin cosolventes polares como el etanol [denominados superfluidos (SFS)]. Los biopolímeros biodegradables se disuelven en SFS y se mezclan con vacunas de subunidades en una solución acuosa o como una suspensión de nanopartículas. Por lo tanto, se están desarrollando nuevas tecnologías de adyuvantes para vacunas para fabricar nanoesferas de polímero biodegradables (PNS) a través de nuevos procesos, lo que permite a los fabricantes de vacunas descartar el uso de disolventes orgánicos. Por lo tanto, los avances tecnológicos probablemente traerán nuevas tendencias en el mercado de adyuvantes para vacunas en los próximos años.
Descripción general del mercado de adyuvantes para vacunas en Oriente Medio y África
El mercado de adyuvantes para vacunas en Oriente Medio y África se ha segmentado en Arabia Saudita, Sudáfrica, los Emiratos Árabes Unidos y el resto de Oriente Medio y África. El aumento de las aprobaciones de productos es un factor importante para el crecimiento positivo del mercado de adyuvantes para vacunas en Arabia Saudita. Las aprobaciones de productos por parte de la SAFDA mejorarán la adopción de vacunas adyuvantes y acelerarán su adopción en los próximos años en Arabia Saudita, impulsando el crecimiento del mercado de 2020 a 2030.
Ingresos y pronóstico del mercado de adyuvantes para vacunas en Oriente Medio y África hasta 2030 (millones de USD)
Segmentación del mercado de adyuvantes para vacunas en Oriente Medio y África
El mercado de adyuvantes para vacunas en Oriente Medio y África se clasifica en clase de adyuvante, tipo y país.
Según la clase de adyuvante, el mercado de adyuvantes para vacunas en Oriente Medio y África se segmenta en adyuvante de sal mineral, adyuvante de emulsión, adyuvante de liposoma y otros. El segmento de adyuvantes de sales minerales tuvo la mayor participación en el mercado de adyuvantes de vacunas de Oriente Medio y África en 2022.
Por tipo, el mercado de adyuvantes de vacunas de Oriente Medio y África se bifurca en adyuvantes de vacunas humanas y adyuvantes de vacunas veterinarias. El segmento de adyuvantes de vacunas humanas tuvo una mayor participación en el mercado de adyuvantes de vacunas de Oriente Medio y África en 2022.
Por país, el mercado de adyuvantes de vacunas de Oriente Medio y África está segmentado en Arabia Saudita, Sudáfrica, los Emiratos Árabes Unidos y el resto de Oriente Medio y África. Arabia Saudita dominó la participación de mercado de adyuvantes de vacunas de Oriente Medio y África en 2022.
Croda International Plc; CSL Ltd; GSK Plc; Novavax Inc; y Phibro Animal Health Corp son algunas de las empresas líderes que operan en el mercado de adyuvantes de vacunas de Oriente Medio y África.
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Middle East & Africa Vaccine Adjuvants Market – Key Market Dynamics
4.1 Middle East & Africa Vaccine Adjuvants Market – Key Market Dynamics
4.2 Market Drivers
4.2.1 Rising Number of Infectious Disease Outbreaks and Pandemic
4.2.2 Approvals of Veterinary Vaccine Adjuvants
4.3 Market Restraints
4.3.1 Product Recalls and Adverse Effects
4.4 Market Opportunities
4.4.1 Advancements in Biotechnology and Immunology
4.5 Future Trends
4.5.1 Technological Advancements
4.6 Impact of Drivers and Restraints:
5. Vaccine Adjuvants Market –Middle East & Africa Market Analysis
5.1 Middle East & Africa Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)
5.2 Middle East & Africa Vaccine Adjuvants Market Forecast and Analysis
6. Middle East & Africa Vaccine Adjuvants Market Analysis –by Adjuvant Class
6.1 Overview
6.2 Mineral Salt Adjuvant
6.2.1 Overview
6.2.2 Mineral Salt Adjuvant: Middle East & Africa Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)
6.3 Emulsion Adjuvant
6.3.1 Overview
6.3.2 Emulsion Adjuvant: Middle East & Africa Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)
6.4 Liposome Adjuvant
6.4.1 Overview
6.4.2 Liposome Adjuvant: Middle East & Africa Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)
6.5 Others
6.5.1 Overview
6.5.2 Others: Middle East & Africa Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)
7. Middle East & Africa Vaccine Adjuvants Market Analysis – by Type
7.1 Human Vaccine Adjuvant
7.1.1 Overview
7.1.2 Human Vaccine Adjuvant: Middle East & Africa Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)
7.2 Veterinary Vaccine Adjuvant
7.2.1 Overview
7.2.2 Veterinary Vaccine Adjuvant: Middle East & Africa Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)
8. Middle East & Africa Vaccine Adjuvants Market –Country Analysis
8.1 Middle East & Africa
8.1.1 Middle East & Africa: Vaccine Adjuvants Market – Revenue and Forecast Analysis – by Country
8.1.1.1 Saudi Arabia: Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)
8.1.1.1.1 Overview
8.1.1.1.2 Saudi Arabia: Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)
8.1.1.1.3 Saudi Arabia: Vaccine Adjuvants Market Breakdown, by Adjuvant Class
8.1.1.1.4 Saudi Arabia: Vaccine Adjuvants Market Breakdown, by Type
8.1.1.2 South Africa: Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)
8.1.1.2.1 Overview
8.1.1.2.2 South Africa: Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)
8.1.1.2.3 South Africa: Vaccine Adjuvants Market Breakdown, by Adjuvant Class
8.1.1.2.4 South Africa: Vaccine Adjuvants Market Breakdown, by Type
8.1.1.3 United Arab Emirates: Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)
8.1.1.3.1 Overview
8.1.1.3.2 United Arab Emirates: Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)
8.1.1.3.3 United Arab Emirates: Vaccine Adjuvants Market Breakdown, by Adjuvant Class
8.1.1.3.4 United Arab Emirates: Vaccine Adjuvants Market Breakdown, by Type
8.1.1.4 Rest of Middle East and Africa Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)
8.1.1.4.1 Overview
8.1.1.4.2 Rest of Middle East and Africa Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)
8.1.1.4.3 Rest of Middle East and Africa Vaccine Adjuvants Market Breakdown, by Adjuvant Class
8.1.1.4.4 Rest of Middle East and Africa Vaccine Adjuvants Market Breakdown, by Type
9. Industry Landscape
9.1 Overview
9.2 Growth Strategies in the Global Vaccine Adjuvants Market
9.3 Organic Developments
9.3.1 Overview
9.4 Inorganic Developments
9.4.1 Overview
10. Company Profiles
10.1 GSK Plc
10.1.1 Key Facts
10.1.2 Business Description
10.1.3 Products and Services
10.1.4 Financial Overview
10.1.5 SWOT Analysis
10.1.6 Key Developments
10.2 CSL Ltd
10.2.1 Key Facts
10.2.2 Business Description
10.2.3 Products and Services
10.2.4 Financial Overview
10.2.5 SWOT Analysis
10.2.6 Key Developments
10.3 Croda International Plc
10.3.1 Key Facts
10.3.2 Business Description
10.3.3 Products and Services
10.3.4 Financial Overview
10.3.5 SWOT Analysis
10.3.6 Key Developments
10.4 Novavax Inc
10.4.1 Key Facts
10.4.2 Business Description
10.4.3 Products and Services
10.4.4 Financial Overview
10.4.5 SWOT Analysis
10.4.6 Key Developments
10.5 Phibro Animal Health Corp
10.5.1 Key Facts
10.5.2 Business Description
10.5.3 Products and Services
10.5.4 Financial Overview
10.5.5 SWOT Analysis
10.5.6 Key Developments
11. Appendix
11.1 About The Insight Partners
List of Tables
Table 1. Middle East & Africa Vaccine Adjuvants Market Segmentation
Table 2. Middle East & Africa Vaccine Adjuvants Market Revenue and Forecasts To 2030 (US$ Million)
Table 3. Saudi Arabia: Vaccine Adjuvants Market – Revenue and Forecast to 2030(US$ Million) – by Adjuvant Class
Table 4. Saudi Arabia: Vaccine Adjuvants Market – Revenue and Forecast to 2030(US$ Million) – by Type
Table 5. South Africa: Vaccine Adjuvants Market – Revenue and Forecast to 2030(US$ Million) – by Adjuvant Class
Table 6. South Africa: Vaccine Adjuvants Market – Revenue and Forecast to 2030(US$ Million) – by Type
Table 7. United Arab Emirates: Vaccine Adjuvants Market – Revenue and Forecast to 2030(US$ Million) – by Adjuvant Class
Table 8. United Arab Emirates: Vaccine Adjuvants Market – Revenue and Forecast to 2030(US$ Million) – by Type
Table 9. Rest of Middle East and Africa Vaccine Adjuvants Market – Revenue and Forecast to 2030(US$ Million) – by Adjuvant Class
Table 10. Rest of Middle East and Africa Vaccine Adjuvants Market – Revenue and Forecast to 2030(US$ Million) – by Type
Table 11. Organic Developments Done by Companies
Table 12. Inorganic Developments Done by Companies
List of Figures
Figure 1. Middle East & Africa Vaccine Adjuvants Market Segmentation, by Country
Figure 2. Impact Analysis of Drivers and Restraints
Figure 3. Middle East & Africa Vaccine Adjuvants Market Revenue (US$ Million), 2022–2030
Figure 4. Middle East & Africa Vaccine Adjuvants Market Share (%) – by Adjuvant Class (2022 and 2030)
Figure 5. Mineral Salt Adjuvant: Middle East & Africa Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)
Figure 6. Emulsion Adjuvant: Middle East & Africa Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)
Figure 7. Liposome Adjuvant: Middle East & Africa Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)
Figure 8. Others: Middle East & Africa Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)
Figure 9. Middle East & Africa Vaccine Adjuvants Market Share (%) – by Type (2022 and 2030)
Figure 10. Human Vaccine Adjuvant: Middle East & Africa Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)
Figure 11. Veterinary Vaccine Adjuvant: Middle East & Africa Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)
Figure 12. Middle East and Africa Vaccine Adjuvants Market by Key Countries – Revenue 2022 (US$ Million)
Figure 13. Middle East and Africa Vaccine Adjuvants Market Breakdown, by Key Countries, 2022 and 2030 (%)
Figure 14. Saudi Arabia: Vaccine Adjuvants Market – Revenue and Forecast to 2030(US$ Million)
Figure 15. South Africa: Vaccine Adjuvants Market – Revenue and Forecast to 2030(US$ Million)
Figure 16. United Arab Emirates: Vaccine Adjuvants Market – Revenue and Forecast to 2030(US$ Million)
Figure 17. Rest of Middle East and Africa Vaccine Adjuvants Market – Revenue and Forecast to 2030(US$ Million)
Figure 18. Growth Strategies in the Vaccine Adjuvants Market
- Croda International Plc
- CSL Ltd
- GSK Plc
- Novavax Inc
- Phibro Animal Health Corp
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Middle East & Africa vaccine adjuvants market.
- Highlights key business priorities to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the Middle East & Africa vaccine adjuvants market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
- Scrutinize in-depth Middle East & Africa market trends and outlook coupled with the factors driving the Middle East & Africa vaccine adjuvants market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution.